SUNWIN - let`s go sweet....jetzt erst recht!!!! (Seite 5301)

[Sheep_2001]

Antwort auf Beitrag Nr.: 36.216.026 von xero1972 am 16.12.08 17:57:35

Da bewegt sich ja gar nichts drüben?
Dachte nach dem Meldung kommt bissel Schwung rein...

[ollerkeim]

also ich denk heute wird hier bissel was nach oben laufen. in amiland geht das ask bei 0,22$ los und der doofe nite liegt zur zeit bei 0,45$ ned wie immer bei 0,17 oder so.

also denke heute ist mal gurte anlegen angesagt.

[MagicWeasel]

Hört sich doch gut an:

Sunwin International Reports Profitable 2009 Second Quarter
(Market Wire 12.17 14:54:19)

Q2 2009 Net Income up 135%, Positioning for Increased Global and USA Stevia Demand



QUFU, CHINA -- (Marketwire) -- 12/17/08 -- Sunwin International Neutraceuticals, Inc.
(OTCBB: SUWN), a leader in the production and distribution of Chinese
herbs, veterinary medicines and one of the world's leading producers of all
natural, zero calorie Stevia in China, today announced its second quarter
results for fiscal 2009 for the quarter ended October 31, 2008.



The quarter showed continued growth in revenue and a significant rise in
net income even as the company increased general and administrative
expenses ahead of further global sales growth. Recent developments in the
US market where Stevia is pending FDA approval as a sweetener ingredient
include an announcement by Coca Cola to launch in the US an all natural low
calorie beverage using Stevia and comments by Pepsi Co. of products
launched in markets outside the US. Sunwin is positioned to become the
largest independent Stevia provider able to supply across the US market for
table top, wholesale and bulk sale needs.



Financial Highlights:



Revenues for the second quarter of fiscal 2009 increased 15.4% to $6.56
million as compared to revenues of $5.68 million in the second quarter of
fiscal 2008. Net income in the second quarter of fiscal 2009 was
approximately $421,000, a 135% increase compared to approximately $179,000
in the second quarter of fiscal 2008.



For the first half of fiscal 2009, revenue increased 29.2% to $12.79
million and net income increased 47.5% to more than $715,000. Gross margins
remain steady at approximately 25% reflecting variances and offsets in
costs related to the global economic upheavals affecting the cost of raw
materials, energy and shipping. The company was able to control costs in
order to maintain its current margins.





The significant increase in quarter over quarter net income was primarily
attributable to ongoing revenue growth, cost controls and efficiency gains
within the business, less increased general and administrative expenses
associated with the company's organic and strategic growth. Selling
expenses declined year over year. Income from operations net of these
changes increased 192% on a quarter to quarter comparison. Sunwin also
became a tax payer in China reducing the current year quarterly net income
by $92,430 compared to no income taxes paid in the prior year quarter.
First half net income was reduced by $166,600 in taxes year to date
compared to the prior year period of zero taxes paid.



The fiscal second quarter is the major purchasing period for Stevia raw
leaf stock by the Company and as a result, inventories increased through
raw materials purchases from $4.7 million at fiscal 2008 year end to $9.2
million at the end of the second quarter ahead of expected demand. While
inventories increased substantially, cash and cash equivalents as of
October 31, 2008 were $6.78 million, down only slightly from $6.81 million
at fiscal 2008 year end. This demonstrates the company's increasing ability
to generate internal working capital to fund its growth programs as it
addresses the increasing worldwide demand for Stevia products.



President and Chairman Laiwang Zhang, commented, "Sunwin posted yet another
strong quarter of growth, profit and conservative fiscal management of the
company's assets. The company made significant inventory purchases to
increase stevia production to meet expected growth in global demand,
eventually to include expected high US market demand as product
manufacturers are openly discussing their plans to launch low calorie
products using Stevia upon FDA approval. Sunwin is uniquely positioned to
address this potential demand as a vertically integrated supplier able to
provide both intermediate grades needed by other producers to create high
grade Stevia, as well as produce and deliver high grade Stevia customized
to a customer's particular needs at competitive costs. In the interim,
Sunwin continues to grow its business outside the US in current and
recently approved markets to the benefit of the bottom line for our
shareholders."



Outlook:



Sunwin expects to continue its growth in international markets where the
bulk of Stevia sales are today through increased production at its present
facilities and broader distribution of product through wholesale channels,
as well as the provision of mid-grade Stevia to other manufacturers who
face limited supply scenarios of this product critical for the production
of high-grade Stevia.



The company anticipates its acquisition of a 60% interest in Qufu Shengwang
Stevia Biology and Science Company will add revenue and profit in the
quarters ahead by expanding the business base in agricultural products and
profitably monetizing Stevia waste products generated from the production
of Stevia.



Sunwin's proprietary OnlySweet(TM) brand of dietary supplements sold in
retail stores across the US continues to grow with increasing interest from
major chain retailers and online distributors. OnlySweet unit sales
increased 34% during the second quarter of 2009 as compared to the prior
year. Expected US approval of Stevia is expected to open further
distribution and sales of the tabletop product currently sold, as well as
significantly increase wholesale and bulk opportunities for the food and
beverage industry in which Sunwin currently participates. Sunwin's customer
Zevia was recently featured as one of the fastest growing companies in its
category, which we believe is a strong indication of the US market
potential for Stevia and Sunwin.



Jeff Reynolds, President of the company's US subsidiary, commented, "The
company continues to see needs for increasing production of both mid-grade
and high-grade Stevia to meet growing global demand, and anticipates demand
increasing upon US FDA approval of Stevia. We believe that US approval will
also open significant interest in launching new products, which will
increase Stevia demand, as well as create additional demand on currently
limited industry production capacity for high-grade Stevia. Sunwin is
uniquely positioned as a vertically integrated producer and seller to meet
the need for high quality Stevia at competitive prices."



Company Background:



Sunwin International Neutraceuticals, Inc. engages in the areas of
essential traditional Chinese medicine, zero calorie natural sweeteners
(stevia), and veterinary medicines and feeds prepared from 100 percent
organic herbal ingredients. As an industry leader in agricultural
processing, Sunwin has built an integrated global firm with the sourcing
and production capabilities to meet the needs of consumers throughout the
world. Sunwin also makes such value-added products as specialty veterinary
food ingredients and specialty feed ingredients. For more info about
Sunwin, please visit http://www.sunwininternational.com



Safe Harbor Statement



In connection with the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995, Sunwin International Neutraceuticals, Inc.,
is hereby providing cautionary statements identifying important factors
that could cause our actual results to differ materially from those
projected in forward-looking statements (as defined in such act). Any
statements that are not historical facts and that express, or involve
discussions as to, expectations, beliefs, plans, objectives, assumptions or
future events or performance (often, but not always, indicated through the
use of words or phrases such as "will likely result," "are expected to,"
"will continue," "is anticipated," "estimated," "intends," "plans,"
"believes" and "projects") may be forward-looking and may involve estimates
and uncertainties which could cause actual results to differ materially
from those expressed in the forward-looking statements. These statements
include, but are not limited to, our guidance and expectations regarding
revenues, net income and earnings. In addition, any such statements are
qualified in their entirety by reference to, and are accompanied by, the
following key factors that have a direct bearing on our results of
operations: our expectations regarding FDA approval of stevia in the US and
the acceptance of stevia in the American consumer market. In addition, any
such statements are qualified in their entirety by reference to, and are
accompanied by, the following key factors that have a direct bearing on our
results of operations: the business operating risks and new and competing
sugar substitutes.



We caution that the factors described herein could cause actual results to
differ materially from those expressed in any forward-looking statements we
make and that investors should not place undue reliance on any such
forward-looking statements. Further, any forward-looking statement speaks
only as of the date on which such statement is made, and we undertake no
obligation to update any forward-looking statement to reflect events or
circumstances after the date on which such statement is made or to reflect
the occurrence of anticipated or unanticipated events or circumstances. New
factors emerge from time to time, and it is not possible for us to predict
all of such factors. Further, we cannot assess the impact of each such
factor on our results of operations or the extent to which any factor, or
combination of factors, may cause actual results to differ materially from
those contained in any forward-looking statements. This press release is
qualified in its entirety by the cautionary statements and risk factor
disclosure contained in our Securities and Exchange Commission filings,
including our Annual Report on Form 10-K for the fiscal year ended April
30, 2008 and our reports on Form 10-Q.





SUNWIN INTERNATIONAL NEUTRACEUTICALS, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS



October 31, April 30,
2008 2008
------------- ------------
ASSETS (Unaudited) (Restated)
CURRENT ASSETS:
Cash $ 6,782,197 $ 6,811,136
Accounts receivable, net 3,741,691 4,163,839
Inventories, net 9,226,294 4,707,044
Taxes receivable 180,441 -
Prepaid expenses and other assets 173,546 264,576
Due from related party 2,173,562 -
Total Current Assets 22,277,731 15,946,594

PROPERTY AND EQUIPMENT 17,234,044 14,151,293
LAND USE RIGHT 2,335,165 -
------------- ------------

Total Assets $ 41,846,940 $ 30,097,887
============= ============

LIABILITIES AND STOCKHOLDERS' EQUITY

CURRENT LIABILITIES:
Accounts payable and accrued expenses $ 4,234,322 $ 2,649,817
Notes payable 100,000 -
Advances from customers - 12,726
Taxes payable 3,610 401,808
Due to related party 65,859 431,443
------------- ------------
Total Current Liabilities 4,403,791 3,495,794

OTHER PAYABLES 157,218 154,207
------------- ------------
Total Liabilities 4,561,009 3,650,001
------------- ------------

MINORITY INTEREST 2,735,369 -
------------- ------------

STOCKHOLDERS' EQUITY:
Preferred stock ($.001 Par Value; 1,000,000
shares authorized;
No shares issued and outstanding) - -
Common stock ($.001 Par Value; 200,000,000
shares authorized; 116,532,712 and 87,006,936
shares issued and outstanding at October 31,
2008 and April 30, 2008, respectively) 116,533 87,007
Additional paid-in capital 23,707,554 17,218,066
Retained earnings 7,041,384 6,325,919
Subscription receivable - (372,900)
Other comprehensive income - foreign currency 3,685,091 3,189,794
------------- ------------
Total Stockholders' Equity 34,550,562 26,447,886
------------- ------------

Total Liabilities and Stockholders' Equity $ 41,846,940 $ 30,097,887
============= ============




SUNWIN INTERNATIONAL NEUTRACEUTICALS, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)


For the Three Months For the Six Months
Ended October 31, Ended October 31,
-------------------------- --------------------------
2008 2007 2008 2007
------------ ------------- ------------ -------------

NET REVENUES $ 6,559,912 $ 5,684,189 $ 12,787,784 $ 9,901,426
COST OF REVENUES 4,912,344 4,220,549 9,630,011 7,094,671

------------ ------------- ------------ -------------
GROSS PROFIT 1,647,568 1,463,640 3,157,773 2,806,755
------------ ------------- ------------ -------------

OPERATING EXPENSES:
Stock-based
consulting
expense 123,748 123,748 247,496 247,496
Selling expenses 463,019 821,843 922,355 1,398,803
General and
administrative 558,802 346,554 1,126,970 705,786
------------ ------------- ------------ -------------
Total Operating
Expenses 1,145,569 1,292,145 2,296,821 2,352,085
------------ ------------- ------------ -------------

INCOME FROM
OPERATIONS 501,999 171,495 860,952 454,670

OTHER INCOME:
Other income 542 1,269 782 1,066
Interest income 11,108 6,109 23,719 31,775
------------ ------------- ------------ -------------
Total Other
Income 11,650 7,378 24,501 32,841
------------ ------------- ------------ -------------

INCOME BEFORE
INCOME TAXES AND
MINORITY INTEREST 513,649 178,873 885,453 487,511

INCOME TAXES (92,430) - (166,600) -
------------ ------------- ------------ -------------

INCOME BEFORE
MINORITY INTEREST 421,219 178,873 718,853 487,511

MINORITY INTEREST
IN INCOME OF
SUBSIDIARIES (3,388) - (3,388) -
------------ ------------- ------------ -------------

NET INCOME 417,831 178,873 715,465 487,511

OTHER COMPREHENSIVE
INCOME:
Unrealized foreign
currency
translation
(loss) gain (119,815) 308,464 495,297 719,320
------------ ------------- ------------ -------------

COMPREHENSIVE
INCOME $ 298,016 $ 487,337 $ 1,210,762 $ 1,206,831
============ ============= ============ =============

NET INCOME PER
COMMON SHARE -
BASIC AND DILUTED:
Net income per
common share -
basic $ 0.00 $ 0.00 $ 0.01 $ 0.01
============ ============= ============ =============
Net income per
common share -
diluted $ 0.00 $ 0.00 $ 0.01 $ 0.01
============ ============= ============ =============

Weighted Common
Shares
Outstanding -
basic 88,304,772 87,006,936 87,652,308 86,779,093
============ ============= ============ =============
Weighted Common
Shares
Outstanding -
diluted 88,304,772 87,006,936 87,652,308 86,779,093
============ ============= ============ =============




CONTACT:
Company:
Jeff Reynolds
972-377-2339
[e-mail]

Investors:
Matt Kreps
469-362-5960
[e-mail]





S.IW .R1 SUWN AG.IW AGES.IW MH.IW MHAL.IW MHHN.IW PB.IW PBBI.IW ED.IW .ERN

[webster79]

das ist absolut richtig!! nur sollte man seine persönliche meinung auch als solche artikulieren. und eben nicht den anspruch auf allgemeingültigkeit erheben... in diesem sinne... auf mehr konstruktive beiträge

[kriegtnix66]

Antwort auf Beitrag Nr.: 36.220.257 von webster79 am 17.12.08 10:06:41

... es ist doch überall das gleiche! Wenn es nicht läuft, wird´s persönlich. Wir kennen uns alle untereinander nicht, aber wir haben eines gemeinsam: Wir interessieren uns für sunwin!
Richtig ist, es darf fast alles geschrieben werden und auch diskutiert werden, aber persönliche Anfeindungen sind einfach nur über! Egal wer schreibt: Anette, Harambee, iceman oder Heinduckdich. Über Inhalte läßt sich reden ...
In diesem Sinne ein frohes Fest und uns allen gute Geschäfte!!!

[webster79]

Antwort auf Beitrag Nr.: 36.219.710 von Apo71 am 17.12.08 08:55:34

hey,

der sinn eines solchen forums ist meiner meinung nach informationsaustausch. und da viele augen mehr sehen, kann es entsprechend konstruktiv sein. also auch hier noch einmal vielen dank für die mühe.
was xero angeht, so habe ich das gefühl, dass er hier soviel zustimmung erfährt, weil er sich extrem viele gedanken um sunwin macht. nur leider hat sich das bei ihm etwas verselbständigt und er verliert sich in auf hypothesen gestützte argumentationsstränge, die spätestens in der dritten folge so fehlerbelastet sind, dass sie mit der realität nicht mehr viel gemein haben können.
er verliert die gesamtstory stevia aus den augen, die auch in der westlichen welt weit älter ist als 20 jahre und jetzt vor einem entscheidenden wendepunkt steht!
was sunwin angeht, so bin ich froh, gerade hier investiert zu sein, weil sie die einzigen sind, die die option auf die realisierung der gesamten wertschöpfung haben. und ich werde mich bestimmt nicht hinstellen und das management als dumm betiteln ohne mich mit ihnen je an einen tisch gesetzt zu haben. aber laut xero ist ja jetzt auch die cocacola führungsebene mit geistiger umnachtung gestraft.... soviel zu xero, mehr werde ich auch in zukunft nicht zu ihm schreiben. ich hoffe nur inständig, dass ihm mal klar wird, was er hier von sich preisgibt und in konsequenz dessen seine postings reduziert, oder sie wenigstens in den von ihm angelegten thread schreibt!

[Apo71]

Antwort auf Beitrag Nr.: 36.215.166 von webster79 am 16.12.08 16:34:44

Moin,

Dank für die Blumen, aber Informationssammlung ist keine intellektuelle Höchstleistung. Gebe Dir Recht - werde meine Posting ab sofort in den Faktenthread stellen.
Ansonsten bin ich sehr froh, daß Xero hier seine Kommentare reinstellt - ich glaube, hier wäre sonst schon lange tote Hose - qualitativ hat das den Thread enorm bereichert, auch wenn das einige anders sehen möchten.

Gruß Apo

[ollerkeim]

ich glaube heute kommt unser spinner drüben nicht so zum zuge wie er gern möchte.

[Whirlwind2]

Gute Zahlen. Umsatz steigt, was will man mehr. Denke in ein paar Monaten wird sich ein warten gelohnt haben... m.M.

[xero1972]

... meine rede :




Campaigners urge against early stevia product launches
By Sarah Hills, 16-Dec-2008

Related topics: Natural sweeteners, Financial & Industry, Sweeteners (intense, bulk, polyols)

As the drive to bring stevia to shop shelves steps up a gear, campaigners urge caution in what they see as a rush to market, saying FDA GRAS must come first.

The Center for Science in the Public Interest said that if stevia products are launched without an official response from the Food and Drug Administration (FDA) on the sweetener’s Gras (generally recognized as safe) status, they should be removed from the shelves until more safety tests have been done.

This, it said, is despite the fact that it is perfectly legal for companies to market whatever food ingredients they want without informing or getting approval from the FDA.

The statement from the CSPI followed reports that Coca-Cola plans to market three flavors of a juice drink in its Odwalla line sweetened with stevia this week, although a spokesman for Coca-Cola North America, declined to comment.

PepsiCo is also poised to launch two drinks sweetened with stevia in the US - SoBe Life Water and Trop 50 – although it has said that it is waiting for the FDA green light first.

Stevia is already permitted for sale in the US as a dietary supplement. However, Merisant Company and Cargill have both notified the FDA that rebiana (the common name for high-purity Rebaudioside A from stevia) should have FDA GRAS for use in food and beverages. The outcome is pending.

Meanwhile the CSPI said that stevia and rebaudioside A may well turn out to be entirely safe, but until more tests have been conducted and analyzed, it would be “reckless” to begin adding it to the food supply.

It added: “The FDA should immediately order those products off the market until all the safety testing has been done.

“Though small amounts of stevia have been consumed in various dietary supplements over the years, apparently without incident, too few safety tests have been done to warrant more general use.”

Safety review

This summer Foodnavigator-USA.com reported that a review of safety data was carried out by toxicologists at the University of California on behalf of the CSPI.

The review said that carcinogenicity studies have not found stevioside (which differs slightly from rebiana) to be carcinogenic in rats but further studies on rebiana, including a study on mice, are needed.

The study concluded that the FDA should require carcinogenicity and toxicology studies both in rats and mice before accepting rebaudioside A as GRAS or approving it as a food additive.

A spokesman for PepsiCo said at the time: “Everyone agrees that no ingredient should be marketed to consumers until its safety has been proven.

“While we believe the full body of evidence presented to the FDA by multiple sweetener manufacturers demonstrates the safety of this ingredient, ultimately it’s up to the FDA to decide.”